These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 35858499)
1. Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: A systematic review. Ostovan VR; Sahraian MA; Karazhian N; Rostamihosseinkhani M; Salimi M; Marbooti H Mult Scler Relat Disord; 2022 Oct; 66():104032. PubMed ID: 35858499 [TBL] [Abstract][Full Text] [Related]
2. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. Pagenkopf C; Südmeyer M J Neuroimmunol; 2021 Sep; 358():577606. PubMed ID: 34182207 [TBL] [Abstract][Full Text] [Related]
3. Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome. Meo SA; Shaikh N; Abukhalaf FA; Meo AS Sci Rep; 2024 Aug; 14(1):18767. PubMed ID: 39138276 [TBL] [Abstract][Full Text] [Related]
5. Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis. Morgan HJ; Clothier HJ; Sepulveda Kattan G; Boyd JH; Buttery JP Vaccine; 2024 Apr; 42(9):2212-2219. PubMed ID: 38350771 [TBL] [Abstract][Full Text] [Related]
6. Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform. Walker JL; Schultze A; Tazare J; Tamborska A; Singh B; Donegan K; Stowe J; Morton CE; Hulme WJ; Curtis HJ; Williamson EJ; Mehrkar A; Eggo RM; Rentsch CT; Mathur R; Bacon S; Walker AJ; Davy S; Evans D; Inglesby P; Hickman G; MacKenna B; Tomlinson L; Ca Green A; Fisher L; Cockburn J; Parry J; Hester F; Harper S; Bates C; Evans SJ; Solomon T; Andrews NJ; Douglas IJ; Goldacre B; Smeeth L; McDonald HI Vaccine; 2022 Jul; 40(32):4479-4487. PubMed ID: 35715350 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report. Tan WY; Yusof Khan AHK; Mohd Yaakob MN; Abdul Rashid AM; Loh WC; Baharin J; Ibrahim A; Ismail MR; Inche Mat LN; Wan Sulaiman WA; Basri H; Hoo FK BMC Neurol; 2021 Oct; 21(1):395. PubMed ID: 34641797 [TBL] [Abstract][Full Text] [Related]
8. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature. Jarius S; Bieber N; Haas J; Wildemann B J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110 [TBL] [Abstract][Full Text] [Related]
9. A systematic review of cases of CNS demyelination following COVID-19 vaccination. Ismail II; Salama S J Neuroimmunol; 2022 Jan; 362():577765. PubMed ID: 34839149 [TBL] [Abstract][Full Text] [Related]
10. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D Front Immunol; 2021; 12():653786. PubMed ID: 33981305 [TBL] [Abstract][Full Text] [Related]
11. MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination. Dams L; Kraemer M; Becker J Mult Scler; 2022 Jun; 28(7):1159-1162. PubMed ID: 34931927 [TBL] [Abstract][Full Text] [Related]
13. Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database. Nguyen S; Bastien E; Chretien B; Sassier M; Defer G; Nehme A; Lelong-Boulouard V; Alexandre J; Fedrizzi S; Morice PM Ann Neurol; 2022 Dec; 92(6):1080-1089. PubMed ID: 36054163 [TBL] [Abstract][Full Text] [Related]
14. Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review. Anamnart C; Tisavipat N; Owattanapanich W; Apiwattanakul M; Savangned P; Prayoonwiwat N; Siritho S; Rattanathamsakul N; Jitprapaikulsan J Mult Scler Relat Disord; 2022 Feb; 58():103414. PubMed ID: 35216789 [TBL] [Abstract][Full Text] [Related]
15. Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature. Maroufi SF; Naderi Behdani F; Rezania F; Tanhapour Khotbehsara S; Mirzaasgari Z Hum Vaccin Immunother; 2022 Dec; 18(1):2040239. PubMed ID: 35240927 [TBL] [Abstract][Full Text] [Related]
16. Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Notghi AA; Atley J; Silva M Clin Med (Lond); 2021 Sep; 21(5):e535-e538. PubMed ID: 34507942 [TBL] [Abstract][Full Text] [Related]
17. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 Vaccine-Associated Uveitis in Patients With a History of Uveitis. Kim J; Kwon HY; Ahn SJ JAMA Ophthalmol; 2024 Jun; 142(6):522-528. PubMed ID: 38662361 [TBL] [Abstract][Full Text] [Related]
19. Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France. Botton J; Jabagi MJ; Bertrand M; Baricault B; Drouin J; Le Vu S; Weill A; Farrington P; Zureik M; Dray-Spira R Ann Intern Med; 2022 Sep; 175(9):1250-1257. PubMed ID: 35994748 [TBL] [Abstract][Full Text] [Related]
20. Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco. Ezzikouri S; Tajudeen R; Majidi H; Redwane S; Aqillouch S; Abdulaziz M; Aragaw M; Papa Fallah M; Sembuche S; Batcho S; Kabwe P; Gonese E; Laazaazia O; Elmessaoudi-Idrissi M; Meziane N; Ainahi A; Sarih M; Ogwell Ouma AE; Maaroufi A Sci Rep; 2024 Apr; 14(1):7817. PubMed ID: 38570577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]